Abstract
Volanesorsen (Waylivra (R)), an antisense oligonucleotide inhibitor of apolipoprotein CIII (apoCIII) mRNA, is being developed by Ionis Pharmaceuticals......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
